Mesoblast (MEOBF) Total Non-Current Liabilities (2017 - 2025)
Mesoblast (MEOBF) has disclosed Total Non-Current Liabilities for 9 consecutive years, with $84.6 million as the latest value for Q2 2025.
- Quarterly Total Non-Current Liabilities fell 26.78% to $84.6 million in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $84.6 million through Jun 2025, down 26.78% year-over-year, with the annual reading at $84.6 million for FY2025, 26.78% down from the prior year.
- Total Non-Current Liabilities hit $84.6 million in Q2 2025 for Mesoblast, down from $115.6 million in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $125.6 million in Q2 2023 to a low of $69.0 million in Q2 2021.
- Historically, Total Non-Current Liabilities has averaged $101.7 million across 5 years, with a median of $113.7 million in 2022.
- Biggest five-year swings in Total Non-Current Liabilities: surged 64.71% in 2022 and later decreased 26.78% in 2025.
- Year by year, Total Non-Current Liabilities stood at $69.0 million in 2021, then soared by 64.71% to $113.7 million in 2022, then grew by 10.44% to $125.6 million in 2023, then fell by 7.99% to $115.6 million in 2024, then decreased by 26.78% to $84.6 million in 2025.
- Business Quant data shows Total Non-Current Liabilities for MEOBF at $84.6 million in Q2 2025, $115.6 million in Q2 2024, and $125.6 million in Q2 2023.